BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 20422495)

  • 21. The bile salt export pump (BSEP) in health and disease.
    Kubitz R; Dröge C; Stindt J; Weissenberger K; Häussinger D
    Clin Res Hepatol Gastroenterol; 2012 Dec; 36(6):536-53. PubMed ID: 22795478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic cholestasis, causes and consequences for hepatobiliary transport.
    Jansen PL; Sturm E
    Liver Int; 2003 Oct; 23(5):315-22. PubMed ID: 14708891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BSEP inhibition: in vitro screens to assess cholestatic potential of drugs.
    Kis E; Ioja E; Rajnai Z; Jani M; Méhn D; Herédi-Szabó K; Krajcsi P
    Toxicol In Vitro; 2012 Dec; 26(8):1294-9. PubMed ID: 22120137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The bile salt export pump: molecular properties, function and regulation.
    Arrese M; Ananthanarayanan M
    Pflugers Arch; 2004 Nov; 449(2):123-31. PubMed ID: 15578267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the bile salt export pump, BSEP, in acquired forms of cholestasis.
    Stieger B
    Drug Metab Rev; 2010 Aug; 42(3):437-45. PubMed ID: 20028269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tauroursodeoxycholic acid inserts the bile salt export pump into canalicular membranes of cholestatic rat liver.
    Dombrowski F; Stieger B; Beuers U
    Lab Invest; 2006 Feb; 86(2):166-74. PubMed ID: 16344857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zebrafish abcb11b mutant reveals strategies to restore bile excretion impaired by bile salt export pump deficiency.
    Ellis JL; Bove KE; Schuetz EG; Leino D; Valencia CA; Schuetz JD; Miethke A; Yin C
    Hepatology; 2018 Apr; 67(4):1531-1545. PubMed ID: 29091294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoimmune BSEP disease: disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis.
    Kubitz R; Dröge C; Kluge S; Stross C; Walter N; Keitel V; Häussinger D; Stindt J
    Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):273-84. PubMed ID: 25342496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2.
    Gonzales E; Grosse B; Cassio D; Davit-Spraul A; Fabre M; Jacquemin E
    J Hepatol; 2012 Sep; 57(3):695-8. PubMed ID: 22609309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy.
    Keitel V; Vogt C; Häussinger D; Kubitz R
    Gastroenterology; 2006 Aug; 131(2):624-9. PubMed ID: 16890614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic differences in PFIC2 and BRIC2 correlate with protein stability of mutant Bsep and impaired taurocholate secretion in MDCK II cells.
    Kagawa T; Watanabe N; Mochizuki K; Numari A; Ikeno Y; Itoh J; Tanaka H; Arias IM; Mine T
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G58-67. PubMed ID: 17947449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy.
    Pauli-Magnus C; Lang T; Meier Y; Zodan-Marin T; Jung D; Breymann C; Zimmermann R; Kenngott S; Beuers U; Reichel C; Kerb R; Penger A; Meier PJ; Kullak-Ublick GA
    Pharmacogenetics; 2004 Feb; 14(2):91-102. PubMed ID: 15077010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 4-phenylbutyrate enhances the cell surface expression and the transport capacity of wild-type and mutated bile salt export pumps.
    Hayashi H; Sugiyama Y
    Hepatology; 2007 Jun; 45(6):1506-16. PubMed ID: 17538928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benign recurrent intrahepatic cholestasis associated with mutations of the bile salt export pump.
    Kubitz R; Keitel V; Scheuring S; Köhrer K; Häussinger D
    J Clin Gastroenterol; 2006 Feb; 40(2):171-5. PubMed ID: 16394881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type 2 inositol 1,4,5-trisphosphate receptor modulates bile salt export pump activity in rat hepatocytes.
    Kruglov EA; Gautam S; Guerra MT; Nathanson MH
    Hepatology; 2011 Nov; 54(5):1790-9. PubMed ID: 21748767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver.
    Stieger B; Fattinger K; Madon J; Kullak-Ublick GA; Meier PJ
    Gastroenterology; 2000 Feb; 118(2):422-30. PubMed ID: 10648470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive bile acid profiling in hereditary intrahepatic cholestasis: Genetic and clinical correlations.
    Liu T; Wang RX; Han J; Hao CZ; Qiu YL; Yan YY; Li LT; Wang NL; Gong JY; Lu Y; Zhang MH; Xie XB; Yang JC; You YJ; Li JQ; Knisely AS; Borchers CH; Ling V; Wang JS
    Liver Int; 2018 Sep; 38(9):1676-1685. PubMed ID: 29412511
    [TBL] [Abstract][Full Text] [Related]  

  • 38.  Bile salt export pump deficiency disease: two novel, late onset, ABCB11 mutations identified by next generation sequencing.
    Vitale G; Pirillo M; Mantovani V; Marasco E; Aquilano A; Gamal N; Francalanci P; Conti F; Andreone P
    Ann Hepatol; 2016; 15(5):795-800. PubMed ID: 27493120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Childhood cholestasis and bile transporters].
    Hierro L; Jara P
    Gastroenterol Hepatol; 2005; 28(7):388-95. PubMed ID: 16137474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulatory mechanisms of the bile salt export pump (BSEP/ABCB11) and its role in related diseases.
    Ren T; Pang L; Dai W; Wu S; Kong J
    Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101641. PubMed ID: 33581308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.